Trial intelligence / Profile preview

Early Corticosteroid Cessation vs. Long Term Therapy in Renal Transplant

NCT00650468Phase 4Completed

Sponsor
Astellas Pharma
Start
Nov 1999
Primary completion
Dec 2007
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of tacrolimus + Wuzhi capsule in kidney transplant rejection, sponsored by Astellas Pharma. Started Nov 1999; status: completed.

02

Drugs

tacrolimus + Wuzhi capsule
03

Conditions

kidney transplant rejection

Beyond the preview

Go deeper on NCT00650468.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00650468.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call